RxDoctor Payments Data

Joseph Hoffman

Pulmonary Disease · Park Ridge, NJNPI 1619103629

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,110,962 of the $1,113,615 with a category attached, or 99.8%. 3 manufacturers reported payments, led by Exelixis Inc. at 39.9% of the total. Reporting peaked in 2020 at $383,278 and has fallen 91.9% since, to $31,012 in 2024. Among pulmonary disease clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,113,615in general payments, 2019–2025

Across 80 payments — averaging $13,920 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exelixis Inc.$444K
  • Mallinckrodt Hospital Products Inc.$351K
  • Regeneron$319K

What the payments were for

  • Consulting fees$1,110,962100%
  • Travel & lodging$2,6370%
  • Food & beverage$160%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exelixis Inc.40$444,250
Mallinckrodt Hospital Products Inc.17$350,653
Regeneron23$318,712

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,113,615 in reported general payments places this provider in the 95th percentile of 472 pulmonary disease providers in New Jersey.

See all pulmonary disease providers in New Jersey →

Other pulmonary disease in Park Ridge

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →